Once a growth area in both the United States and Europe, the job market for HIV/AIDS is now flattening out. These days, a scientific career in HIV/AIDS research is more likely to involve clinical-research programmes in developing nations than basic research in Western countries.
In this article, Myrna Watanabe reports that this shift has been driven by funding. The amount of money earmarked for HIV/AIDS is massive, and the focus is now being put on developing countries.
For example, as part of the ‘3 by 5’ initiative announced recently by the World Health Organisation, money will be available for Western scientists to train physicians in the developing world (see Anti-AIDS drugs sought for 3 million). And even in industry, job openings are often linked to those regions most affected by the disease.
Reference: Nature 426, 737 (2003)